A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2013.02.092

Cited by (1,005)

Items 501–600 of 1,005

  1. Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
    Zile, Michael R., Borlaug, Barry A., Kramer, Christopher M., Baum, Seth J., Litwin, Sheldon E., Menon, Venu, Ou, Yang, Weerakkody, Govinda J., Hurt, Karla C., Kanu, Chisom et al. · 2025 · Circulation
  2. The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
    Withaar, Coenraad, Meems, Laura M.G., Nollet, Edgar E., Schouten, E. Marloes, Schroeder, Marie A., Knudsen, Lotte B., Niss, Kristoffer, Madsen, Christian T., Hoegl, Annabelle, Mazzoni, Gianluca et al. · 2023 · JACC: Basic to Translational Science
  3. Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary
    Michael W. Rich, Deborah Ann Chyun, Adam H. Skolnick, Karen P. Alexander, Daniel E. Forman, Dalane W. Kitzman, Mathew S. Maurer, James B. McClurken, Barbara M. Resnick, Win K. Shen et al. · 2016 · Journal of the American Geriatrics Society
  4. Lipotoxicity: a driver of heart failure with preserved ejection fraction?
    Jennifer Leggat, Guillaume Bidault, Antonio Vidal‐Puig · 2021 · Clinical Science
  5. Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger
    Anshul S. Jadli, Ananya Parasor, Karina Pereira Gomes, Ruchita Shandilya, Vaibhav B. Patel · 2021 · Frontiers in Cardiovascular Medicine
  6. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
    Jayanth Ranjit Arnold, Prathap Kanagala, Charley Ann Budgeon, Michael Jerosch‐Herold, Gaurav Singh Gulsin, Anvesha Singh, Jamal Nasir Khan, Daniel C. S. Chan, Iain B Squire, Leong L. Ng et al. · 2022 · JACC. Cardiovascular imaging
  7. Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction
    Daniel Daou, Thomas G. Gillette, Joseph A. Hill · 2023 · Physiology
  8. Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results
    Carolyn S.P. Lam, Lars H. Lund, Sanjiv Jayendra Shah, Adriaan A. Voors, David Erlinge, Antti Saraste, Carlo Pirazzi, Erik Lerkevang Grove, Anders L Barasa, Morten Schou et al. · 2023 · Journal of Cardiac Failure
  9. Emerging importance of oxidative stress in regulating striated muscle elasticity
    Lisa Beckendorf, Wolfgang Albrecht Linke · 2014 · Journal of Muscle Research and Cell Motility
  10. Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction
    Barry A. Borlaug, Gregory D. Lewis, Steven E. McNulty, Marc J. Semigran, Martin M. LeWinter, Horng Chen, Grace Lin, Anita M Deswal, Kenneth B. Margulies, Margaret M. Redfield · 2015 · Circulation Heart Failure
  11. The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
    Constantijn Franssen, A. González Miqueo · 2016 · Netherlands Heart Journal
  12. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4
    Timothy D. O’Connell, Robert Block, Shue Huang, Gregory C. Shearer · 2016 · Journal of Molecular and Cellular Cardiology
  13. sST2 as a value-added biomarker in heart failure
    Manuela Lotierzo, Anne‐Marie Dupuy, Eran Kalmanovich, François Roubille, Jean‐Paul Cristol · 2019 · Clinica Chimica Acta
  14. Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction
    Caroline Zotter‐Tufaro, Julia Mascherbauer, Franz Duca, Benedikt Koell, Stefan Aschauer, Andreas Anselm Kammerlander, Adelheid Panzenboeck, Roela Sadushi‐Kolici, Christine Bangert, Daniela Laimer et al. · 2015 · JACC Heart Failure
  15. Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?
    Gandhi, Parul U., Gaggin, Hanna K., Sheftel, Alex D., Belcher, Arianna M., Weiner, Rory B., Baggish, Aaron L., Motiwala, Shweta R., Liu, Peter P., Januzzi, James L. · 2014 · The American Journal of Cardiology
  16. Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential
    Emmanuel S. Buys, D.P. Zimmer, Jennifer G. Chickering, Regina Margaret Graul, Yueh‐tyng Chien, Albert T. Profy, John R. Hadcock, Jaime L. Masferrer, G. Todd Milne · 2018 · Nitric Oxide
  17. Energy metabolism disorders and potential therapeutic drugs in heart failure
    Yanan He, Wei Huang, Chen Zhang, Lumeng Chen, Runchun Xu, Nan Li, Fang Wang, Li Han, Ming Yang, Dingkun Zhang · 2020 · Acta Pharmaceutica Sinica B
  18. Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
    Pankaj Garg, Hosamadin S. Assadi, Rachel S. Jones, Wei Bin Chan, Peter Metherall, Richard G. Thomas, Rob J. van der Geest, Andrew J. Swift, Abdallah Al‐Mohammad · 2021 · Scientific Reports
  19. Anemia of cardiorenal syndrome
    Peter Andrew McCullough · 2021 · Kidney International Supplements
  20. Cardiac Endothelial Cell Transcriptome
    Achim Lother, Stella Bergemann, Lisa Deng, Martin Moser, Christoph Bode, Lutz Hein · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
  21. Older Adults, “Malignant” Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure
    Stephen L. Seliger, James A. de Lemos, Ian J. Neeland, Robert H. Christenson, John S. Gottdiener, Mark H. Drazner, Jarett D. Berry, John David Sorkin, Christopher R. deFilippi · 2015 · JACC Heart Failure
  22. Large Animal Models of Heart Failure
    Kleiton Augusto Santos Silva, Craig A. Emter · 2020 · JACC Basic to Translational Science
  23. Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
    Jennifer E. Ho, Margaret M. Redfield, Gregory D. Lewis, Walter J. Paulus, Carolyn S.P. Lam · 2020 · Circulation
  24. Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure
    Huihui Li, Chen Chen, Dao Wen Wang · 2021 · Frontiers in Physiology
  25. Adenosine and Adenosine Receptor-Mediated Action in Coronary Microcirculation
    Zhang, Ying, Wernly, Bernhard, Cao, Xin, Mustafa, S. Jamal, Tang, Yong, Zhou, Zhichao · 2021 · Basic Research in Cardiology
  26. Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
    Teresa Salvatore, Alfredo Caturano, Raffaele Galiero, Anna Di Martino, Gaetana Albanese, Erica Vetrano, Celestino Sardu, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso · 2021 · Biomedicines
  27. Diabetic cardiomyopathy
    Ana Lorenzo-Almorós, J.M. Cepeda-Rodrigo, Óscar Lorenzo · 2020 · Revista Clínica Española (English Edition)
  28. Epidemiology of heart failure in diabetes: a disease in disguise
    Anna G. Hoek, Elisa Dal Canto, Eva Wenker, Navin R. Bindraban, M. Louis Handoko, Petra J. M. Elders, Joline W. J. Beulens · 2024 · Diabetologia
  29. Pathophysiological insights into HFpEF from studies of human cardiac tissue
    Ahmed U. Fayyaz, Muhammad Eltony, Larry J. Prokop, Katlyn E. Koepp, Barry A. Borlaug, Surendra Dasari, Melanie C. Bois, Kenneth B. Margulies, Joseph John Maleszewski, Ying Wang et al. · 2024 · Nature Reviews Cardiology
  30. Diabetes-Related Heart Failure
    Yoshiyuki Bando, Toyoaki Murohara · 2014 · Circulation Journal
  31. Heart Failure With Preserved Ejection Fraction Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors
    Josep Lupón, Giovana Gavidia‐Bovadilla, Elena Ferrer, Marta de Antonio, Alexandre Perera-Lluna, Jorge López‐Ayerbe, Mar Domingo, Julio E. Núñez, Elisabet Zamora, Pedro Moliner et al. · 2019 · Circulation Heart Failure
  32. Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
    Laween Uthman, Marius C. Kuschma, Gregor Römer, Marleen Boomsma, Jens Keßler, Jeroen Hermanides, Markus Werner Hollmann, Benedikt Preckel, Coert Jozef Zuurbier, Nina Claudia Weber · 2020 · Cardiovascular Drugs and Therapy
  33. Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg?
    Michael Douglas Nelson, Janet Wei, C. Noel Bairey Merz · 2017 · European Heart Journal
  34. Omega-3, Omega-6 and Omega-9 Fatty Acids: Implications for Cardiovascular and Other Diseases
    Melissa Johnson · 2014 · Journal of Glycomics & Lipidomics
  35. Global Differences in Heart Failure With Preserved Ejection Fraction
    Jasper Tromp, Brian Lee Claggett, Jiankang Liu, Alice M. Jackson, Pardeep S. Jhund, Lars Køber, Jiri Widimsky Jr., Sergey Anatol'evich Boytsov, Vijay Chopra, Inder S. Anand et al. · 2021 · Circulation Heart Failure
  36. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction
    Ning Zhang, Qunchao Ma, Yayu You, Xiangyang Xia, Cuiping Xie, Yuxue Huang, Zhuo Wang, Feiming Ye, Zhaosheng Yu, Xiaojie Xie · 2022 · International Journal of Biological Sciences
  37. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
    Lauriane Cornuault, Paul Rouault, Cécile Duplàa, Thierry Couffinhal, Marie‐Ange Renault · 2022 · Frontiers in Physiology
  38. Novel Pathomechanisms of Cardiomyocyte Dysfunction in a Model of Heart Failure with Preserved Ejection Fraction
    Uwe Primeßnig, Patrick Schönleitner, Alexander Höll, Susanne Pfeiffer, Taja Bracic, Thomas Rau, Martin Kapl, Tatjana Stojaković, Toma Nikolaev Glasnov, Kirsten Leineweber et al. · 2016 · European Journal of Heart Failure
  39. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum
    Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, Ulf Dahlström, Magnus Edner, Lars H. Lund · 2019 · International Journal of Cardiology
  40. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction
    Lam, Carolyn SP · 2015 · Diabetes and Vascular Disease Research
  41. Myeloperoxidase and Related Biomarkers are Suggestive Footprints of Endothelial Microvascular Inflammation in HFpEF Patients
    Camilla Hage, Erik Michaëlsson, Bengt Kull, Tasso Miliotis, Sara Svedlund, Cecilia Marianne Linde, Erwan Donal, Jean‐Claude Daubert, Li‐Ming Gan, Lars H. Lund · 2020 · ESC Heart Failure
  42. Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation
    Jianmin Chen, Lucy Victoria Norling, Dianne Cooper · 2021 · Cells
  43. Novel insights about albumin in cardiovascular diseases: Focus on heart failure
    Beatrice Zoanni, Maura Brioschi, Alice Mallia, Erica Gianazza, Sonia Eligini, M. Carini, Giancarlo Aldini, Cristina Banfi · 2021 · Mass Spectrometry Reviews
  44. Decoding the Liver-Heart Axis in Cardiometabolic Diseases
    Federico Capone, Antonio Vacca, Guillaume Bidault, Dylan C. Sarver, Dorota Kamińska, Stefano Strocchi, Antonio Vidal‐Puig, Carolina M. Greco, Aldons Jake Lusis, Gabriele G. Schiattarella · 2025 · Circulation Research
  45. Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
    Vanessa P. M. van Empel, Justin A. Mariani, Barry A. Borlaug, David M. Kaye · 2014 · Journal of the American Heart Association
  46. Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults
    Robert C. Kaplan, David B. Hanna, Jorge R. Kizer · 2016 · Current HIV/AIDS Reports
  47. Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction
    Christoph Sinning, Tibor Kempf, Michael Schwarzl, Simon Lanfermann, Francisco Ojeda, Renate B. Schnabel, Elvin Zengin, Philipp Sebastian Wild, Karl Johannes Lackner, Thomas F. Münzel et al. · 2016 · International Journal of Cardiology
  48. The alternative complement pathway is dysregulated in patients with chronic heart failure
    Negar Shahini, Annika Elisabet Michelsen, Per H. Nilsson, Karin Ekholt, Lars Lysgaard Gullestad, Kaspar Broch, Christen Peder Dahl, Pål Aukrust, Thor Ueland, Tom Eirik Mollnes et al. · 2017 · Scientific Reports
  49. El cociente entre la grasa abdominal visceral y la subcutánea evaluado por tomografía computarizada es un predictor independiente de mortalidad y eventos cardiacos
    Ricardo Ladeiras‐Lopes, Francisco Sampaio, Nuno Bettencourt, Ricardo Fontes‐Carvalho, Nuno Dias Ferreira, Adelino Ferreira Leite-Moreira, Vasco Gama · 2017 · Revista Española de Cardiología
  50. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction
    Hirofumi Saiki, Gilles Moulay, Adam J. Guenzel, Weibin Liu, Teresa D. Decklever, Kelly L. Classic, Linh Pham, Horng H. Chen, John C. Jr Burnett, Stephen J. Russell et al. · 2017 · American Journal of Physiology-Heart and Circulatory Physiology
  51. Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes
    Ekaterina S. Ovchinnikova, Martijn F. Hoes, Kirill Ustyantsev, Nils Bömer, Tristan V. de Jong, H.C. van der Mei, Eugène Berezikov, Peter van der Meer · 2018 · Stem Cell Reports
  52. Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
    Heng Zeng, Jian‐Xiong Chen · 2019 · Frontiers in Cardiovascular Medicine
  53. Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF
    Kitzman, Dalane W., Nicklas, Barbara J. · 2018 · JACC: Heart Failure
  54. The Role of Adipose Triglyceride Lipase and Cytosolic Lipolysis in Cardiac Function and Heart Failure
    Ulrich Kintscher, Anna Foryst‐Ludwig, Guenter Haemmerle, Rudolf Zechner · 2020 · Cell Reports Medicine
  55. Vitamin K2—a neglected player in cardiovascular health: a narrative review
    Essa H. Hariri, Nicholas Kassis, Jean‐Pierre Iskandar, Leon J. Schurgers, Anas M. Saad, Omar Abdelfattah, Agam Bansal, Toshiaki Isogai, Serge C. Harb, Samir Kapadia · 2021 · Open Heart
  56. Endothelial cell dysfunction in cardiac disease: driver or consequence?
    Jules D. Allbritton‐King, Guillermo García‐Cardeña · 2023 · Frontiers in Cell and Developmental Biology
  57. Heart Failure with Preserved Ejection Fraction in Older Adults
    Bharathi Upadhya, Dalane W. Kitzman · 2017 · Heart Failure Clinics
  58. Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction
    Alberto Palazzuoli, Gaetano M. Ruocco, Oreste De Vivo, Ranuccio Nuti, Peter Andrew McCullough · 2017 · The American Journal of Cardiology
  59. H 2 FPEF Score
    Walter J. Paulus · 2018 · Circulation
  60. Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
    Abraham D. Abernethy, Syed S Raza, Jie‐Lena Sun, Kevin Joseph Anstrom, Russell P. Tracy, Johannes Steiner, Peter VanBuren, Martin M. LeWinter · 2018 · Journal of the American Heart Association
  61. Myocardial Energetics in Heart Failure With Preserved Ejection Fraction
    Omar F. AbouEzzeddine, Bradley J. Kemp, Barry A. Borlaug, Brian P. Mullan, Atta Behfar, Sorin V. Pislaru, Marat Fudim, Margaret M. Redfield, Panithaya Chareonthaitawee · 2019 · Circulation Heart Failure
  62. Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases
    Teresa Infante, Dario Costa, Claudio Napoli A · 2021 · Angiology
  63. Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study
    Ashwin Venkateshvaran, Ulrika Ljung Faxén, Camilla Hage, Erik Michaëlsson, Sara Svedlund, Antti Saraste, Lauren Beussink‐Nelson, Maria Lagerstrom Fermer, Li‐Ming Gan, Jasper Tromp et al. · 2022 · European Journal of Heart Failure
  64. Metabolic and Immune Crosstalk in Cardiovascular Disease
    Sarajo Kumar Mohanta, Coraline Heron, Alexandra Klaus‐Bergmann, Hauke Horstmann, Ebba Bråkenhielm, Chiara Giannarelli, Andreas J. R. Habenicht, Holger Gerhardt, Christian Weber · 2025 · Circulation Research
  65. Atrial Cardiomyopathy: From Healthy Atria to Atrial Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC
    Jerremy Weerts, Otilia Țica, Julia A. Aranyo, Christian Basile, Angelina Borizanova, Josip A. Borovac, Massimiliano Camilli, Martin Eichenlaub, Emiliano Fiori, Tim van Loon et al. · 2025 · European Journal of Heart Failure
  66. Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression
    Xiongwei Xie · 2016 · Biomedicine & Pharmacotherapy
  67. IL-33 (Interleukin 33)/sST2 Axis in Hypertension and Heart Failure
    Rana Ghali, Raffaele Altara, William Edward Louch, Alessandro Cataliotti, Ziad Mallat, Abdullah Kaplan, Fouad Anthony Zouein, George W. Booz · 2018 · Hypertension
  68. Myocardial Titin and Collagen in Cardiac Diastolic Dysfunction
    Nazha Hamdani, Walter J. Paulus · 2013 · Circulation
  69. Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women
    Hena N Patel, Neelum T. Aggarwal, Anupama Rao, Elizabeth Bryant, Rupa Mehta Sanghani, Mary Byrnes, Dinesh Kumar Kalra, Leigh Dairaghi, Lynne T. Braun, Sherine E. Gabriel et al. · 2020 · Journal of Women s Health
  70. Fibroblast Growth Factor 23: A Biomarker of Fibrosis and Prognosis in Heart Failure with Preserved Ejection Fraction
    Clotilde Roy, Sibille Lejeune, Alisson Slimani, Christophe de Meester, Sylvie A. Ahn, Michel F. Rousseau, Mihaela Silvia Amzulescu, Audrey Ginion, Benjamin Ferracin, Agnès Pasquet et al. · 2020 · ESC Heart Failure
  71. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
    Liyun Zhang, Juan Chen, Lianhua Yan, Qin He, Han Xie, Manhua Chen · 2021 · Frontiers in Pharmacology
  72. Biomarkers in Heart Failure with Preserved Ejection Fraction
    Antoni Bayés‐Genís, Germán Cediel, Mar Domingo, Pau Codina, Evelyn Santiago‐Vacas, Josep Lupón · 2022 · Cardiac failure review
  73. Red Cell Distribution Width and Mortality in Acute Heart Failure Patients With Preserved and Reduced Ejection Fraction
    Konstantinos Sotiropoulos, Patrick Yerly, Pierre A Monney, Antoine Garnier, Julien Regamey, Olivier Hügli, David J. Martin, Mélanie Metrich, Jean‐Philippe Antonietti, Roger Hullin · 2016 · ESC Heart Failure
  74. Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
    Marta Michalska, Agata Magdalena Bielecka-Dabrowa, Stephan von Haehling, Stefan D. Anker, Jacek Rysz, Maciej Banach · 2018 · Archives of Medical Science
  75. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction
    Zainab Albar, Marwah M. Albakri, Jamal Hajjari, Mohamad Karnib, Scott E. Janus, Sadeer G Al-Kindi · 2022 · The American Journal of Cardiology
  76. Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
    Sha Chen, Qian Wang, Diane Bakker, Xin Yang Hu, Liping Zhang, Ingeborg van der Made, Anna M. Tebbens, Csenger Kovácsházi, Zoltán Giricz, Gábor B. Brenner et al. · 2024 · Basic Research in Cardiology
  77. The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction
    Julio A. Chirinos, Payman L. Zamani · 2016 · Current Heart Failure Reports
  78. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
    Milton Packer · 2019 · Journal of Cardiac Failure
  79. Heart Failure with Preserved Ejection Fraction—a Concise Review
    Daria Adamczak, Mary-Tiffany Adannia Oduah, Thomas Kiebalo, Sonia Nartowicz, Marcin Bęben, Mateusz Pochylski, Aleksandra Ciepłucha, Adrian Gwizdała, Maciej Lesiak, Ewa Straburzyńska‐Migaj · 2020 · Current Cardiology Reports
  80. NETosis as a Pathogenic Factor for Heart Failure
    Shuang Ling, Jin‐Wen Xu · 2021 · Oxidative Medicine and Cellular Longevity
  81. Similarities and Differences Between HFmrEF and HFpEF
    Peixin Li, Hengli Zhao, Jianyu Zhang, Yunshan Ning, Yan Tu, Dingli Xu, Qingchun Zeng · 2021 · Frontiers in Cardiovascular Medicine
  82. Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve
    Emanuele Gallinoro, Pasquale Paolisso, Alessandro Candreva, Konstantinos Bermpeis, Davide Fabbricatore, Giuseppe Esposito, Dario Tino Bertolone, Estefanıa Fernández‐Peregrina, Daniel Munhoz, Niya Boykova Mileva et al. · 2021 · Frontiers in Cardiovascular Medicine
  83. Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
    Ren Jie Phang, Rebecca Helen Ritchie, Derek John Hausenloy, Jarmon G. Lees, Shiang Yong Lim · 2022 · Cardiovascular Research
  84. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
    Vasiliki Tsigkou, Evangelos K. Oikonomou, Artemis Anastasiou, Stamatios Lampsas, George Ε. Zakynthinos, Konstantinos I. Kalogeras, Maria Katsioupa, Maria Kapsali, Islam Kourampi, Theodoros Pesiridis et al. · 2023 · International Journal of Molecular Sciences
  85. CoQ10Function and Role in Heart Failure and Ischemic Heart Disease
    Anita Ayer, Peter Simon Macdonald, Roland Stocker · 2015 · Annual Review of Nutrition
  86. Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction
    Bernadet T. Santema, Mariëlle Kloosterman, Isabelle C. Van Gelder, Ify R. Mordi, Chim Choy Lang, Carolyn S.P. Lam, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos et al. · 2018 · European Heart Journal
  87. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
    Julian Friebel, Alice Weithäuser, Marco Witkowski, Bernhard Hermann Rauch, Konstantinos Savvatis, Andrea Dörner, Termeh Tabaraie, Mario Kašner, Verena Moos, Diana Bösel et al. · 2019 · European Heart Journal
  88. Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure
    Sameer Prasada, Adovich S. Rivera, Arvind Nishtala, Anna E. Pawlowski, Arjun Sinha, Joshua D. Bundy, Simran Arinder Chadha, Faraz S. Ahmad, Sadiya S. Khan, Chad J. Achenbach et al. · 2020 · JACC Heart Failure
  89. Do Most Patients with Obesity or Type 2 Diabetes, and Atrial Fibrillation, Also have Undiagnosed Heart Failure? A Critical Conceptual Framework for Understanding Mechanisms and Improving Diagnosis and Treatment
    Milton Packer · 2019 · European Journal of Heart Failure
  90. RhoA: a dubious molecule in cardiac pathophysiology
    Lucia Sophie Kilian, Jakob Christoph Voran, Derk Frank, Ashraf Yusuf Rangrez · 2021 · Journal of Biomedical Science
  91. Emerging role of liver X receptors in cardiac pathophysiology and heart failure
    Megan V. Cannon, Wiek H. van Gilst, Rudolf A. de Boer · 2015 · Basic Research in Cardiology
  92. Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community
    IJsbrand Thomas Klip, Adriaan A. Voors, Dorine W. Swinkels, Stephan J. L. Bakker, Jenny E. Kootstra‐Ros, Carolyn S.P. Lam, Pim van der Harst, Dirk Jan van Veldhuisen, Peter van der Meer · 2016 · European Journal of Heart Failure
  93. Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes
    Salvatore, Teresa, Galiero, Raffaele, Caturano, Alfredo, Vetrano, Erica, Rinaldi, Luca, Coviello, Francesca, Di Martino, Anna, Albanese, Gaetana, Colantuoni, Sara, Medicamento, Giulia et al. · 2022 · Biomolecules
  94. Central Cardiac Limit to Aerobic Capacity in Patients With Exertional Pulmonary Venous Hypertension
    Mário Santos, Alexander R. Opotowsky, Amil M. Shah, Julie A. Tracy, Aaron B. Waxman, David M. Systrom · 2014 · Circulation Heart Failure
  95. Traditional Chinese Medicine Ginseng Dingzhi Decoction Ameliorates Myocardial Fibrosis and High Glucose‐Induced Cardiomyocyte Injury by Regulating Intestinal Flora and Mitochondrial Dysfunction
    Junyan Wang, Peiwen Chen, Qiuyu Cao, Wei Wang, Xing Chang · 2022 · Oxidative Medicine and Cellular Longevity
  96. Sex-Based Differences in Heart Failure
    Sadiya S. Khan, Lauren Brittany Beach, Clyde W. Yancy · 2022 · Journal of the American College of Cardiology
  97. Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and Health
    Myrthe M. A. Willemars, Miranda Nabben, Job A.J. Verdonschot, Martijn F. Hoes · 2022 · Current Heart Failure Reports
  98. Inflammation in HFpEF: Key or circumstantial?
    Vanessa P. M. van Empel, Hans‐Peter Brunner‐La Rocca · 2015 · International Journal of Cardiology
  99. Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure With Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis)
    Michael G. Silverman, Birju Patel, Ron Blankstein, João A.C. Lima, Roger Scott Blumenthal, Khurram Nasir, Michael Joseph Blaha · 2016 · The American Journal of Cardiology
  100. Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis
    Stefano Piaserico, Elena Osto, Giulia Famoso, Irene Zanetti, Darío Gregori, Anna Poretto, Sabino Iliceto, Andrea Peserico, Francesco Tona · 2016 · Atherosclerosis